Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $5.7M invested in Bio-Rad Laboratories Class B in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.04% less ownership
Funds ownership: 0.36% → 0.32% (-0.04%)
16% less capital invested
Capital invested by funds: $6.8M → $5.7M (-$1.09M)
22% less funds holding
Funds holding: 9 → 7 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$258K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Copperwynd Financial
Scottsdale,
Arizona
|
-$657K |
| 2 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
-$211K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$176K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $4.76M | – | – | – |
|
|
2
Renaissance Technologies
New York
| $703K | +$258K | +700 | +54% |
|
3
Morgan Stanley
New York
| $182K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $33K | -$176K | -477 | -83% |
|
5
Wells Fargo
San Francisco,
California
| $20K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
CF
7
Copperwynd Financial
Scottsdale,
Arizona
| – | -$657K | -1,777 | Closed |
|
|
GI
8
GAMCO Investors
Greenwich,
Connecticut
| – | -$211K | -570 | Closed |
|
9
Osaic Holdings
Scottsdale,
Arizona
| – | +$368 | +1 | New |
|
BIO.B Hedge Fund Activity: Q1 2020 in Review
7 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2020, worth a combined $5.7M — down 16% from $6.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIO.B and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $258K. The largest seller was Copperwynd Financial, exiting entirely with an estimated $657K sold.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $5.7M of Bio-Rad Laboratories Class B stock for Q1 2020, down 16% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q1 2020 and 2 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2020 was Renaissance Technologies, an estimated $258K added.
- The largest Bio-Rad Laboratories Class B seller in Q1 2020 was Copperwynd Financial, an estimated $657K sold.
Based on aggregated 13F filings for Q1 2020.